Article
Low immunogenic bio-nanocapsule based on hepatitis B virus escape mutants.
Nanomedicine : nanotechnology, biology, and medicine - 1 Feb 2018
Jung Joohee, Somiya Masaharu, Jeong Seong-Yun, Choi Eun Kyung, Kuroda Shun'ichi
Abstract excerpt
Bio-nanocapsules (BNCs) consisting of hepatitis B virus surface antigen (HBsAg) L proteins and phospholipids are used as efficient non-viral carriers for liver-specific delivery of genes and drugs. Considering the administration to HB vaccinees and HB patients, endogenous anti-HBsAg immunoglobulins (HBIGs) may reduce the delivery efficacy and prevent repetitive administration. Therefore, low immunogenic BNCs were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
